Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

With certain government data currently being withheld, removed, or restored but partially redacted on the websites of the U.S. Centers for Disease Control and Prevention and Food and Drug ...

A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...

Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...